首页> 外文期刊>Clinics >Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
【24h】

Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors

机译:肉毒杆菌毒素和普萘洛尔治疗原发性和张力性声震的比较

获取原文
获取外文期刊封面目录资料

摘要

OBJECTIVES: Vocal tremors, which cause social difficulties for patients, may be classified as resting or action tremors. Of the vocal action tremors, essential and dystonic tremors are the most common. Botulinum toxin and oral medications have been used to treat vocal tremors, but no comparative clinical trials have been performed. The aim of this study was to compare the effects of botulinum toxin injection and the oral administration of propranolol in the treatment of essential and dystonic vocal tremors. METHODS: This clinical trial recruited 15 patients, divided into essential and dystonic vocal tremor groups. Patients in both groups received successive treatment with botulinum toxin and propranolol. The treatments were administered at different times; the order of treatment was randomly selected. Patients were assessed with flexible nasofibrolaryngoscopy and with perceptual and acoustic voice evaluations. A statistical significance level of 0.05 (5%) was used. RESULTS: Botulinum toxin produced statistically significant improvements in perceptual measures of vocal instability in patients with dystonic vocal tremors compared with baseline values and treatment with propranolol. The acoustic measure of variability in the fundamental frequency was significantly lower in patients with dystonic vocal tremors after treatment with botulinum toxin. CONCLUSION: Essential and dystonic vocal tremors responded differently to treatment. Dystonic vocal tremors responded significantly to treatment with botulinum toxin but not oral propranolol. Essential vocal tremors did not respond significantly to either treatment, perhaps due to the small number of patients, which is a limitation of this research.
机译:目的:引起患者社交困难的声震可分为静息震颤或动作震颤。在声带性震颤中,原发性和肌张力性震颤是最常见的。肉毒杆菌毒素和口服药物已用于治疗声震,但尚未进行比较临床试验。这项研究的目的是比较肉毒杆菌毒素注射和普萘洛尔口服治疗原发性和张力性声震的疗效。方法:该临床试验招募了15例患者,分为原发性和强直性声震颤组。两组患者均接受了肉毒杆菌毒素和心得安的连续治疗。治疗在不同的时间进行;治疗顺序是随机选择的。患者接受了灵活的鼻前鼻喉镜检查以及知觉和听觉语音评估。统计显着性水平为0.05(5%)。结果:与基线值和普萘洛尔治疗相比,肌张力障碍性声音震颤患者的声音不稳定性知觉测量方面,肉毒杆菌毒素产生了统计学上显着的改善。经肉毒杆菌毒素治疗的肌张力异常性震颤患者的基本频率变异性的声学测量值明显较低。结论:原发性和肌张力性震颤对治疗的反应不同。肌张力障碍性震颤对肉毒杆菌毒素治疗有明显反应,但口服普萘洛尔则无此反应。可能由于患者人数少,基本的人声震颤对两种治疗均无明显反应,这是这项研究的局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号